Publication | Closed Access
Overexpression of FOXM1 Is Associated With Poor Prognosis and Clinicopathologic Stage of Pancreatic Ductal Adenocarcinoma
77
Citations
24
References
2012
Year
Our finding indicates that FoxM1 could be used as prognostic molecular marker and therapeutic target for PDA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1